TAKARA BIO INC. Logo

TAKARA BIO INC.

Provides life science research tools, gene therapies, and CDMO services for improving human health.

4974 | T

Overview

Corporate Details

ISIN(s):
JP3460200003
LEI:
Country:
Japan
Address:
草津市野路東七丁目4番38号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Takara Bio Inc. is a global biotechnology company dedicated to improving human health through innovative life science research tools and gene therapies. The company supplies a comprehensive portfolio of reagents, kits, instruments, and services to researchers focused on gene discovery, regulation, and function. Its offerings support a wide range of applications, including single-cell analysis, sequencing, immune profiling, and stem cell research. Additionally, Takara Bio is a key player in the development of cutting-edge medical technologies, focusing on gene and cell therapies for cancer and other diseases. The company also provides contract development and manufacturing (CDMO) services, supporting partners in the production of therapeutic products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-12 03:15
Registration Form
確認書
Japanese 8.1 KB
2025-11-12 03:13
Interim / Quarterly Report
半期報告書-第24期(2025/04/01-2026/03/31)
Japanese 191.8 KB
2025-06-30 02:46
AGM Information
臨時報告書
Japanese 27.5 KB
2025-06-20 07:27
Registration Form
確認書
Japanese 8.1 KB
2025-06-20 07:26
Governance Information
内部統制報告書-第23期(2024/04/01-2025/03/31)
Japanese 23.6 KB
2025-06-20 07:24
Annual Report
有価証券報告書-第23期(2024/04/01-2025/03/31)
Japanese 1.7 MB
2025-05-13 09:11
Board/Management Information
臨時報告書
Japanese 21.8 KB
2024-11-11 02:37
Regulatory Filings
確認書
Japanese 8.1 KB
2024-11-11 02:36
Interim / Quarterly Report
半期報告書-第23期(2024/04/01-2025/03/31)
Japanese 167.8 KB
2024-07-01 04:07
AGM Information
訂正臨時報告書
Japanese 36.9 KB
2024-06-28 04:30
AGM Information
臨時報告書
Japanese 27.3 KB
2024-06-27 06:14
Governance Information
内部統制報告書-第22期(2023/04/01-2024/03/31)
Japanese 22.7 KB
2024-06-27 06:13
Registration Form
確認書
Japanese 8.1 KB
2024-06-27 06:12
Annual Report
有価証券報告書-第22期(2023/04/01-2024/03/31)
Japanese 1.8 MB
2024-02-14 07:42
Report Publication Announcement
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all TAKARA BIO INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TAKARA BIO INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TAKARA BIO INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Addex Therapeutics Ltd. Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland
ADXN
ADIAL PHARMACEUTICALS, INC. Logo
Develops personalized, genetically-targeted drugs for treating Alcohol Use Disorder and addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Developing off-the-shelf gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET
Adlai Nortye Ltd. Logo
Clinical-stage biopharma developing innovative targeted and immuno-oncology therapies.
United States of America
ANL
ADMA BIOLOGICS, INC. Logo
End-to-end biopharma making plasma-derived biologics for immune-compromised patients.
United States of America
ADMA
Adverum Biotechnologies, Inc. Logo
Developing single-injection gene therapies for prevalent ocular diseases like wet AMD.
United States of America
ADVM
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France
ALDVI
AegirBio AB Logo
Develops user-friendly, saliva-based tests for health monitoring & therapeutic drug monitoring.
Sweden
AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Developing therapeutic neurotoxins for medical conditions like migraines and cervical dystonia.
United States of America
AEON

Talk to a Data Expert

Have a question? We'll get back to you promptly.